<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">32839185</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>03</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>04</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Electronic-Print">
        <Journal>
          <ISSN IssnType="Electronic">1098-5522</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>88</Volume>
            <Issue>11</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Oct</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>Infection and immunity</Title>
          <ISOAbbreviation>Infect Immun</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Distinct Mycoplasma pneumoniae Interactions with Sulfated and Sialylated Receptors.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">e00392-20</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1128/IAI.00392-20</ELocationID>
        <Abstract>
          <AbstractText><i>Mycoplasma pneumoniae</i> is a cell wall-less bacterial pathogen of the conducting airways, causing bronchitis and atypical or "walking" pneumonia in humans. <i>M. pneumoniae</i> recognizes sialylated and sulfated oligosaccharide receptors to colonize the respiratory tract, but the contribution of the latter is particularly unclear. We used chamber slides coated with sulfatide (3-<i>O</i>-sulfogalactosylceramide) to provide a baseline for <i>M. pneumoniae</i> binding and gliding motility. As expected, <i>M. pneumoniae</i> bound to surfaces coated with sulfatide in a manner that was dependent on sulfatide concentration and incubation temperature and inhibited by competing dextran sulfate. However, mycoplasmas bound to sulfatide exhibited no gliding motility, regardless of receptor density. <i>M. pneumoniae</i> also bound lactose 3'-sulfate ligated to an inert polymer scaffold, and binding was inhibited by competing dextran sulfate. The major adhesin protein P1 mediates adherence to terminal sialic acids linked α-2,3, but P1-specific antibodies that blocked <i>M. pneumoniae</i> hemadsorption (HA) and binding to the sialylated glycoprotein laminin by 95% failed to inhibit mycoplasma binding to sulfatide, suggesting that P1 does not mediate binding to sulfated galactose. Consistent with this conclusion, the <i>M. pneumoniae</i> HA-negative mutant II-3 failed to bind to sialylated receptors but adhered to sulfatide in a temperature-dependent manner.</AbstractText>
          <CopyrightInformation>Copyright © 2020 American Society for Microbiology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Williams</LastName>
            <ForeName>Caitlin R</ForeName>
            <Initials>CR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, University of Georgia, Athens, Georgia, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Li</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, University of Georgia, Athens, Georgia, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>College of Engineering, University of Georgia, Athens, Georgia, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>New Materials Institute, University of Georgia, Athens, Georgia, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sheppard</LastName>
            <ForeName>Edward S</ForeName>
            <Initials>ES</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, University of Georgia, Athens, Georgia, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chopra</LastName>
            <ForeName>Pradeep</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Locklin</LastName>
            <ForeName>Jason</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, University of Georgia, Athens, Georgia, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>College of Engineering, University of Georgia, Athens, Georgia, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>New Materials Institute, University of Georgia, Athens, Georgia, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Boons</LastName>
            <ForeName>Geert-Jan</ForeName>
            <Initials>GJ</Initials>
            <AffiliationInfo>
              <Affiliation>Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Krause</LastName>
            <ForeName>Duncan C</ForeName>
            <Initials>DC</Initials>
            <Identifier Source="ORCID">0000-0003-3548-0422</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, University of Georgia, Athens, Georgia, USA dkrause@uga.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>P41 GM103390</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 AI110098</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Infect Immun</MedlineTA>
        <NlmUniqueID>0246127</NlmUniqueID>
        <ISSNLinking>0019-9567</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D006023">Glycoproteins</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001422" MajorTopicYN="N">Bacterial Adhesion</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001426" MajorTopicYN="N">Bacterial Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006023" MajorTopicYN="N">Glycoproteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009177" MajorTopicYN="N">Mycoplasma pneumoniae</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011019" MajorTopicYN="N">Pneumonia, Mycoplasma</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Mycoplasma pneumoniae
</Keyword>
        <Keyword MajorTopicYN="Y">adherence</Keyword>
        <Keyword MajorTopicYN="Y">receptor-ligand interaction</Keyword>
        <Keyword MajorTopicYN="Y">sialic acid</Keyword>
        <Keyword MajorTopicYN="Y">sulfated glycan</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32839185</ArticleId>
        <ArticleId IdType="pmc">PMC7573437</ArticleId>
        <ArticleId IdType="doi">10.1128/IAI.00392-20</ArticleId>
        <ArticleId IdType="pii">IAI.00392-20</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Waites KB, Atkinson TP. 
2009. 
The role of Mycoplasma in upper respiratory infections. Curr Infect Dis Rep
11:198–206. doi:10.1007/s11908-009-0030-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11908-009-0030-6</ArticleId>
            <ArticleId IdType="pubmed">19366562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Atkinson TP, Balish MF, Waites KB. 
2008. 
Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev
32:956–973. doi:10.1111/j.1574-6976.2008.00129.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1574-6976.2008.00129.x</ArticleId>
            <ArticleId IdType="pubmed">18754792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Korppi M, Heiskanen-Kosma T, Kleemola M. 
2004. 
Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology
9:109–114. doi:10.1111/j.1440-1843.2003.00522.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1440-1843.2003.00522.x</ArticleId>
            <ArticleId IdType="pubmed">14982611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin RJ, Kraft M, Chu HW, Berns EA, Cassell GH. 
2001. 
A link between chronic asthma and chronic infection. J Allergy Clin Immunol
107:595–601. doi:10.1067/mai.2001.113563.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1067/mai.2001.113563</ArticleId>
            <ArticleId IdType="pubmed">11295645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biberfeld G, Biberfeld P. 
1970. 
Ultrastructural features of Mycoplasma pneumoniae. J Bacteriol
102:855–861. doi:10.1128/JB.102.3.855-861.1970.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.102.3.855-861.1970</ArticleId>
            <ArticleId IdType="pmc">PMC247637</ArticleId>
            <ArticleId IdType="pubmed">4914084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Collier AM, Clyde WA Jr. 
1971. 
Relationships between Mycoplasma pneumoniae and human respiratory epithelium. Infect Immun
3:694–701. doi:10.1128/IAI.3.5.694-701.1971.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.3.5.694-701.1971</ArticleId>
            <ArticleId IdType="pmc">PMC416218</ArticleId>
            <ArticleId IdType="pubmed">16558038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hasselbring BM, Krause DC. 
2007. 
Cytoskeletal protein P41 is required to anchor the terminal organelle of the wall-less prokaryote Mycoplasma pneumoniae. Mol Microbiol
63:44–53. doi:10.1111/j.1365-2958.2006.05507.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2958.2006.05507.x</ArticleId>
            <ArticleId IdType="pubmed">17163973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu PC, Collier AM, Baseman JB. 
1977. 
Surface parasitism by Mycoplasma pneumoniae of respiratory epithelium. J Exp Med
145:1328–1343. doi:10.1084/jem.145.5.1328.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.145.5.1328</ArticleId>
            <ArticleId IdType="pmc">PMC2180664</ArticleId>
            <ArticleId IdType="pubmed">870608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu PC, Cole RM, Huang YS, Graham JA, Gardner DE, Collier AM, Clyde WA Jr. 
1982. 
Mycoplasma pneumoniae infection: role of a surface protein in the attachment organelle. Science
216:313–315. doi:10.1126/science.6801766.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.6801766</ArticleId>
            <ArticleId IdType="pubmed">6801766</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baseman JB, Cole RM, Krause DC, Leith DK. 
1982. 
Molecular basis for cytadsorption of Mycoplasma pneumoniae. J Bacteriol
151:1514–1522. doi:10.1128/JB.151.3.1514-1522.1982.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.151.3.1514-1522.1982</ArticleId>
            <ArticleId IdType="pmc">PMC220433</ArticleId>
            <ArticleId IdType="pubmed">6809731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krause DC, Leith DK, Wilson RM, Baseman JB. 
1982. 
Identification of Mycoplasma pneumoniae proteins associated with hemadsorption and virulence. Infect Immun
35:809–817. doi:10.1128/IAI.35.3.809-817.1982.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.35.3.809-817.1982</ArticleId>
            <ArticleId IdType="pmc">PMC351120</ArticleId>
            <ArticleId IdType="pubmed">6802761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krause DC, Baseman JB. 
1983. 
Inhibition of Mycoplasma pneumoniae hemadsorption and adherence to respiratory epithelium by antibodies to a membrane protein. Infect Immun
39:1180–1186. doi:10.1128/IAI.39.3.1180-1186.1983.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.39.3.1180-1186.1983</ArticleId>
            <ArticleId IdType="pmc">PMC348081</ArticleId>
            <ArticleId IdType="pubmed">6404820</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cloward JM, Krause DC. 
2009. 
Mycoplasma pneumoniae J-domain protein required for terminal organelle function. Mol Microbiol
71:1296–1307. doi:10.1111/j.1365-2958.2009.06602.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2958.2009.06602.x</ArticleId>
            <ArticleId IdType="pmc">PMC5833977</ArticleId>
            <ArticleId IdType="pubmed">19183275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cloward JM, Krause DC. 
2011. 
Loss of co-chaperone TopJ impacts adhesin P1 presentation and terminal organelle maturation in Mycoplasma pneumoniae. Mol Microbiol
81:528–539. doi:10.1111/j.1365-2958.2011.07712.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2958.2011.07712.x</ArticleId>
            <ArticleId IdType="pmc">PMC3134135</ArticleId>
            <ArticleId IdType="pubmed">21631602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krause DC, Shi J, Chen S, Jensen A, Sheppard ES, Jensen GJ. 
2018. 
Electron cryotomography of Mycoplasma pneumoniae correlates terminal organelle architectural features and function. Mol Microbiol
108:306–318. doi:10.1111/mmi.13937.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/mmi.13937</ArticleId>
            <ArticleId IdType="pmc">PMC5912986</ArticleId>
            <ArticleId IdType="pubmed">29470845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Waldo RH III, Jordan JL, Krause DC. 
2005. 
Identification and complementation of a mutation associated with loss of Mycoplasma pneumoniae virulence-specific proteins B and C. J Bacteriol
187:747–751. doi:10.1128/JB.187.2.747-751.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.187.2.747-751.2005</ArticleId>
            <ArticleId IdType="pmc">PMC543562</ArticleId>
            <ArticleId IdType="pubmed">15629945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Layh-Schmitt G, Podtelejnikov A, Mann M. 
2000. 
Proteins complexed to the P1 adhesin of Mycoplasma pneumoniae. Microbiol
146:741–747. doi:10.1099/00221287-146-3-741.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/00221287-146-3-741</ArticleId>
            <ArticleId IdType="pubmed">10746778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakane D, Adan-Kubo J, Kenri T, Miyata M. 
2011. 
Isolation and characterization of P1 adhesin, a leg protein of the gliding bacterium Mycoplasma pneumoniae. J Bacteriol
193:715–722. doi:10.1128/JB.00796-10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.00796-10</ArticleId>
            <ArticleId IdType="pmc">PMC3021217</ArticleId>
            <ArticleId IdType="pubmed">21097617</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hansen EJ, Wilson RM, Baseman JB. 
1979. 
Two-dimensional gel electrophoretic comparison of proteins from virulent and avirulent strains of Mycoplasma pneumoniae. Infect Immun
24:468–475. doi:10.1128/IAI.24.2.468-475.1979.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.24.2.468-475.1979</ArticleId>
            <ArticleId IdType="pmc">PMC414325</ArticleId>
            <ArticleId IdType="pubmed">457282</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baseman JB, Morrison-Plummer J, Drouillard D, Puleo-Scheppke B, Tryon VV, Holt SC. 
1987. 
Identification of a 32-kilodalton protein of Mycoplasma pneumoniae associated with hemadsorption. Isr J Med Sci
23:474–479.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3117727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Romero-Arroyo CE, Jordan J, Peacock SJ, Willby MJ, Farmer MA, Krause DC. 
1999. 
Mycoplasma pneumoniae protein P30 is required for cytadherence and associated with proper cell development. J Bacteriol
181:1079–1087. doi:10.1128/JB.181.4.1079-1087.1999.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.181.4.1079-1087.1999</ArticleId>
            <ArticleId IdType="pmc">PMC93483</ArticleId>
            <ArticleId IdType="pubmed">9973332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hasselbring BM, Jordan JL, Krause DC. 
2005. 
Mutant analysis reveals a specific requirement for protein P30 in Mycoplasma pneumoniae gliding motility. J Bacteriol
187:6281–6289. doi:10.1128/JB.187.18.6281-6289.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.187.18.6281-6289.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1236621</ArticleId>
            <ArticleId IdType="pubmed">16159760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sobeslavsky O, Prescott B, Chanock RM. 
1968. 
Adsorption of Mycoplasma pneumoniae to neuraminic acid receptors of various cells and possible role in virulence. J Bacteriol
96:695–705. doi:10.1128/JB.96.3.695-705.1968.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.96.3.695-705.1968</ArticleId>
            <ArticleId IdType="pmc">PMC252361</ArticleId>
            <ArticleId IdType="pubmed">4183967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Loomes LM, Uemura K, Childs RA, Paulson JC, Rogers GN, Scudder PR, Michalski J-C, Hounsell EF, Taylor-Robinson D, Feizi T. 
1984. 
Erythrocyte receptors for Mycoplasma pneumoniae are sialylated oligosaccharides of Ii antigen type. Nature
307:560–563. doi:10.1038/307560a0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/307560a0</ArticleId>
            <ArticleId IdType="pubmed">6420710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roberts DD, Olson LD, Barile MF, Ginsburg V, Krivan HC. 
1989. 
Sialic acid-dependent adhesion of Mycoplasma pneumoniae to purified glycoproteins. J Biol Chem
264:9289–9293.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2470754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kasai T, Nakane D, Ishida H, Ando H, Kiso M, Miyata M. 
2013. 
Role of binding in Mycoplasma mobile and Mycoplasma pneumoniae gliding analyzed through inhibition by synthesized sialylated compounds. J Bacteriol
195:429–435. doi:10.1128/JB.01141-12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.01141-12</ArticleId>
            <ArticleId IdType="pmc">PMC3554017</ArticleId>
            <ArticleId IdType="pubmed">23123913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen L, Leman D, Williams CR, Brooks K, Krause DC, Locklin J. 
2017. 
Versatile methodology for glycosurfaces: direct ligation of nonderivatized reducing saccharides to poly(pentafluorophenyl acrylate) grafted surfaces via hydrazide conjugation. Langmuir
33:8821–8828. doi:10.1021/acs.langmuir.7b00779.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acs.langmuir.7b00779</ArticleId>
            <ArticleId IdType="pmc">PMC5833976</ArticleId>
            <ArticleId IdType="pubmed">28492327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams CR, Chen L, Driver AD, Arnold EA, Sheppard ES, Locklin J, Krause DC. 
2018. 
Sialylated receptor setting influences Mycoplasma pneumoniae attachment and gliding motility. Mol Microbiol
109:735–744. doi:10.1111/mmi.13997.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/mmi.13997</ArticleId>
            <ArticleId IdType="pmc">PMC6185809</ArticleId>
            <ArticleId IdType="pubmed">29885004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krivan HC, Olson LD, Barile MF, Ginsburg V, Roberts DD. 
1989. 
Adhesion of Mycoplasma pneumoniae to sulfated glycolipids and inhibition by dextran sulfate. J Biol Chem
264:9283–9288.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2470753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prince OA, Krunkosky TM, Krause DC. 
2014. 
In vitro spatial and temporal analysis of Mycoplasma pneumoniae colonization of human airway epithelium. Infect Immun
82:579–586. doi:10.1128/IAI.01036-13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01036-13</ArticleId>
            <ArticleId IdType="pmc">PMC3911394</ArticleId>
            <ArticleId IdType="pubmed">24478073</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor SL, McGuckin MA, Wesselingh S, Rogers GB. 
2018. 
Infection's sweet tooth: how glycans mediate infection and disease susceptibility. Trends Microbiol
26:92–101. doi:10.1016/j.tim.2017.09.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tim.2017.09.011</ArticleId>
            <ArticleId IdType="pmc">PMC7125966</ArticleId>
            <ArticleId IdType="pubmed">29079498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peng W, de Vries RP, Grant OC, Thompson AJ, McBride R, Tsogtbaatar B, Lee PS, Razi N, Wilson IA, Woods RJ, Paulson JC. 
2017. 
Recent H3N2 viruses have evolved specificity for extended, branched human-type receptors, conferring potential for increased avidity. Cell Host Microbe
21:23–34. doi:10.1016/j.chom.2016.11.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chom.2016.11.004</ArticleId>
            <ArticleId IdType="pmc">PMC5233592</ArticleId>
            <ArticleId IdType="pubmed">28017661</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brennan MJ, Hannah JH, Leininger E. 
1991. 
Adhesion of Bordetella pertussis to sulfatides and to the GalNAc beta 4Gal sequence found in glycosphingolipids. J Biol Chem
266:18827–18831.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1918002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hartmann E, Lingwood CA, Reidl J. 
2001. 
Heat-inducible surface stress protein (Hsp70) mediates sulfatide recognition of the respiratory pathogen Haemophilus influenzae. Infect Immun
69:3438–3441. doi:10.1128/IAI.69.5.3438-3441.2001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.69.5.3438-3441.2001</ArticleId>
            <ArticleId IdType="pmc">PMC98307</ArticleId>
            <ArticleId IdType="pubmed">11292771</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ozcelik P, Bezirci FB, Suzuki Y, Uzawa H, Nishida Y, Kobayashi K, Suzuki T, Miyamoto D, Nagatake T, Ahmed K. 
2006. 
Sulfatide and its synthetic analogues recognition by Moraxella catarrhalis. Microbiol Immunol
50:967–970. doi:10.1111/j.1348-0421.2006.tb03873.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1348-0421.2006.tb03873.x</ArticleId>
            <ArticleId IdType="pubmed">17179664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Degroote S, Ducourouble MP, Roussel P, Lamblin G. 
1999. 
Sequential biosynthesis of sulfated and/or sialylated Lewis x determinants by transferases of the human bronchial mucosa. Glycobiol
9:1199–1211. doi:10.1093/glycob/9.11.1199.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/glycob/9.11.1199</ArticleId>
            <ArticleId IdType="pubmed">10536036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lamblin G, Degroote S, Perini JM, Delmotte P, Scharfman A, Davril M, Lo-Guidice JM, Houdret N, Dumur V, Klein A, Rousse P. 
2001. 
Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis. Glycoconj J
18:661–684. doi:10.1023/a:1020867221861.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/a:1020867221861</ArticleId>
            <ArticleId IdType="pubmed">12386453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lipman RP, Clyde WA Jr, Denny FW. 
1969. 
Characteristics of virulent, attenuated, and avirulent Mycoplasma pneumoniae strains. J Bacteriol
100:1037–1043. doi:10.1128/JB.100.2.1037-1043.1969.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.100.2.1037-1043.1969</ArticleId>
            <ArticleId IdType="pmc">PMC250191</ArticleId>
            <ArticleId IdType="pubmed">5359607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tully JG, Whitcomb RF, Clark HF, Williamson DL. 
1977. 
Pathogenic mycoplasmas: cultivation and vertebrate pathogenicity of a new spiroplasma. Science
195:892–894. doi:10.1126/science.841314.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.841314</ArticleId>
            <ArticleId IdType="pubmed">841314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nashed MA, Musser JH. 
1993. 
A facile and regioselective synthesis of partially benzoylated 3',4'-O-isopropylidene-beta-lactosides as standardized key intermediates for sialyl Lewis X (sLex) analogues. Carbohydr Res
250:C1–C4. doi:10.1016/0008-6215(93)84013-v.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0008-6215(93)84013-v</ArticleId>
            <ArticleId IdType="pubmed">7907528</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bubb WA, Urashima T, Kohso K, Nakamura T, Arai I, Saito T. 
1999. 
Occurrence of an unusual lactose sulfate in dog milk. Carbohydr Res
318:123–128. doi:10.1016/s0008-6215(99)00102-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0008-6215(99)00102-0</ArticleId>
            <ArticleId IdType="pubmed">10515052</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stemke GW, Robertson JA. 
1982. 
Comparison of two methods for enumeration of mycoplasmas. J Clin Microbiol
16:959–961. doi:10.1128/JCM.16.5.959-961.1982.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.16.5.959-961.1982</ArticleId>
            <ArticleId IdType="pmc">PMC272510</ArticleId>
            <ArticleId IdType="pubmed">7153345</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seto S, Kenri T, Tomiyama T, Miyata M. 
2005. 
Involvement of P1 adhesin in gliding motility of Mycoplasma pneumoniae as revealed by the inhibitory effects of antibody under optimized gliding conditions. J Bacteriol
187:1875–1877. doi:10.1128/JB.187.5.1875-1877.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.187.5.1875-1877.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1064011</ArticleId>
            <ArticleId IdType="pubmed">15716461</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
